期刊文献+

肝脏轻链沉积病与轻链型淀粉样变性的临床病理特征

Clinical pathological characteristics of light chain deposition disease and light chain amyloidosis in liver
下载PDF
导出
摘要 目的探讨轻链沉积病(light chain deposition disease,LCDD)和轻链型淀粉样变性(light chain amyloido-sis,AL)累及肝脏的临床病理特征及鉴别诊断。方法回顾性分析北京佑安医院2012-2016年行肝穿刺活体组织检查,光镜初步诊断为肝淀粉样变的8例患者资料,进一步行刚果红染色、偏振光显微镜观察和轻链蛋白κ、λ的免疫组化检测,并分析其临床病理特点。结果 8例怀疑肝淀粉样变的患者均为中老年男性,临床表现为肝脏肿大,γ-谷氨酰转肽酶和碱性磷酸酶升高为主的肝功能异常,以及不同程度的蛋白尿,其中6例证实为AL,2例为LCDD。6例AL刚果红染色肝窦内呈不同程度阳性,2例伴血管壁阳性,其中4例为轻链蛋白κ沉积,2例为轻链蛋白λ沉积。2例LCDD刚果红染色均阴性,且均为轻链蛋白λ沉积。结论以肝脏受累为突出表现的LCDD和AL,临床表现缺乏特异性,与肝脏原发疾病不易鉴别,本病确诊依赖刚果红染色及轻链蛋白检测,临床怀疑肝淀粉样病变时应尽早行肝穿刺活检以明确诊断。 Objective To explore the clinical pathological characteristics and the differential diagnosis of liver light chain deposition disease (LCDD)and light-chain amyloidosis (AL). Methods Liver biopsies from 2012 to 2016 in Beijing You' an Hospital were retrospectively analyzed. Eight hepatic amyloidosis cases were diagnosed. Congo red stain, polarized light microscopy and immunohistochemical detection of light chain protein K, k were used. Then the clinical pathological characteristics were analyzed. Results All the patients were male. Hepatomegaly, increased GGT and ALP, different levels of proteinuria were the prominent clinical manifestations. Six cases were AL, and the other 2 cases were LCDD. Congo red stain was positive in the sinusoids in 6 AL cases, in which 2 cases with vessel wall positive, 4 cases with light chain protein K deposition, 2 cases with light chain protein k deposition. Congo red stain was negative in 2 LCDD cases, with light chain k protein deposition. Conclusion It is not easy to identify liver LCDD and AL from other primary liver diseases through clinical manifestations because that liver LCDD and AL lack clinical specificity. The diag- nosis of these two diseases relies on Congo red stain and light chain protein detection. So when there is clinical suspect of liver amyloid lesion,the patients should undergo liver biopsies in order to make clear diagnosis as early as possible.
出处 《北京医学》 CAS 2016年第9期877-879,I0001,共4页 Beijing Medical Journal
关键词 轻链沉积病 轻链淀粉样变性 肝活检 light chain deposition disease(LCDD) light chain amyloidosis(AL) liver biopsy
  • 相关文献

参考文献10

  • 1Eirin A,Irazabal MV,Gertz MA,et al.Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular- limited deposition in the kidney[J].Nephrol Dial Transplant,2012,27:1097-1101.
  • 2姚英,王素霞,章友康,刘刚,曲贞,邹万忠.肾脏淀粉样变性病的分型诊断及临床特点分析[J].北京医学,2012,34(4):267-270. 被引量:3
  • 3Kumar S,Dispenzieri A,Katzmann JA,et al.Serum immunoglobu- lin free light-chain measurement in primary amyloidosis:prognostic value and correlations with clinical features[J].Blood,2010,116:5126-5129.
  • 4Itabashi M,Takei T,Tsukada M,et al.Association between clinical characteristics and AL amyloid deposition in the kidney[J].Heart Vessels,2010,25:543-548.
  • 5Nasr SH,Valeri AM,Cornell LD,et al.Renal monoclonalimmuno- globulin deposition disease:a report of 64 patients from asingle in- stitution[J].Clin J Am SocNephrol,2012,7:231-239.
  • 6Brilland B,Sayegh J,CroueA,et al.Recovery from LCDD-associat- ed severe liver cholestasis:a case report and literature review [J].J Gastrointestin Liver Dis,2016,25:99-103.
  • 7Dispenzieri A,Gertz MA,Kyle RA,et al.Serum cardiac troponins and N- terminal pro--brain natriuretic peptide:A staging system for primary systemic amyloidosis[J].J clin Oncol,2004,22:3751-3757.
  • 8沈恺妮,李剑.原发性轻链型淀粉样变的治疗进展[J].中国实验血液学杂志,2015,23(3):910-914. 被引量:11
  • 9李晓梅,谌达程,梁丹丹,徐峰,梁少姗,朱小东,张明超,黄湘华,刘志红,曾彩虹.轻链沉积病患者临床病理特征[J].肾脏病与透析肾移植杂志,2016,25(1):1-7. 被引量:11
  • 10Mena- Durdn A,Munoz Vicente E,Pareja Llorens G,et al.Liver failure caused by light chain deposition disease associated with mul- tiple myeloma[J].Intern Med,2012,51:773-776.

二级参考文献68

  • 1Westermark P,Benson MD,Buxbaum JN. Amyloid:toward terminology clarification.Report from the Nomenclature Committee of the International Society of Amyloidosis[J].AMYLOID-INTERNATIONAL Journal OF EXPERIMENTAL AND CLINICAL INVESTIGATION,2005.1-4.
  • 2Dember LM. Amyloidosis-associated kidney disease[J].Journal of the American Society of Nephrology,2006,(12):3458-3571.doi:10.1681/ASN.2006050460.
  • 3Merlini G,Bellotti V. Molecular mechanisms of amyloidosis[J].New England Journal of Medicine,2003.583-596.
  • 4Gertz MA,Comenzo R,Falk RH. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL):a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis,Tours,France,18-22April 2004[J].American Journal of Hematology,2005.319-328.
  • 5武淑兰;孙士斌.浆细胞病--基础与临床[M]北京:北京大学医学出版社,2003147-149.
  • 6Larsen CP,Walker PD,Weiss DT. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies[J].Kidney International,2010.816-819.
  • 7von Hutten H,Mihatsch M,Lobeck H. Prevalence and origin of amyloid in kidney biopsies[J].American Journal of Surgical Pathology,2009.1198-1205.
  • 8Sen S,Sarsik B. A proposed histopathologic classification,scoring,and grading system for renal amyloidosis:standardization of renal amyloid biopsy report[J].Archives of Pathology and Laboratory Medicine,2010.532-544.
  • 9Picken MM. New insights into systemic amyloidosis:the importance of diagnosis of specific type[J].Current Opinion in Nephrology and Hypertension,2007,(3):196-203.doi:10.1097/MNH.0b013e3280bdc0db.
  • 10Katzmann JA,Kyle RA,Benson J,et al.Screening panels for detection of monoclonal gammopathies.Clin Chem,2009;55(8):1517-1522.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部